Optimind Pharma Balance Sheet Health
Financial Health criteria checks 1/6
Optimind Pharma has a total shareholder equity of CA$114.6K and total debt of CA$571.1K, which brings its debt-to-equity ratio to 498.5%. Its total assets and total liabilities are CA$800.2K and CA$685.7K respectively.
Key information
498.5%
Debt to equity ratio
CA$571.13k
Debt
Interest coverage ratio | n/a |
Cash | CA$32.08k |
Equity | CA$114.58k |
Total liabilities | CA$685.67k |
Total assets | CA$800.25k |
Recent financial health updates
No updates
Recent updates
Financial Position Analysis
Short Term Liabilities: OMND's short term assets (CA$185.9K) do not cover its short term liabilities (CA$676.9K).
Long Term Liabilities: OMND's short term assets (CA$185.9K) exceed its long term liabilities (CA$8.8K).
Debt to Equity History and Analysis
Debt Level: OMND's net debt to equity ratio (470.5%) is considered high.
Reducing Debt: Insufficient data to determine if OMND's debt to equity ratio has reduced over the past 5 years.
Balance Sheet
Cash Runway Analysis
For companies that have on average been loss-making in the past, we assess whether they have at least 1 year of cash runway.
Stable Cash Runway: OMND has less than a year of cash runway based on its current free cash flow.
Forecast Cash Runway: OMND has less than a year of cash runway if free cash flow continues to reduce at historical rates of 40.5% each year